AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
7.18
0.00 (-0.07%)
Aug 5, 2026, 10:26 AM EDT - Market open
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $2.65 billion as of August 5, 2026. Its market cap has increased by 193.72% in one year.
Market Cap
2.65B
Enterprise Value
2.43B
1-Year Change
193.72%
Ranking
Category
Stock Price
$7.18
ChartMarket Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has increased from $2.29B to $2.65B, an increase of 15.99%. That is a compound annual growth rate of 2.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 2.65B | 78.68% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Disc Medicine | 2.99B |
| Immunome | 2.79B |
| Beam Therapeutics | 2.76B |
| Kodiak Sciences | 2.64B |
| Trevi Therapeutics | 2.63B |
| Tarsus Pharmaceuticals | 2.63B |
| Nurix Therapeutics | 2.54B |
| Ultragenyx Pharmaceutical | 2.49B |